X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (164) 164
male (109) 109
female (108) 108
middle aged (99) 99
clinical neurology (89) 89
index medicus (69) 69
adult (68) 68
aged (61) 61
parkinson disease - drug therapy (39) 39
parkinson's disease (34) 34
huntington disease - genetics (30) 30
article (28) 28
double-blind method (27) 27
treatment outcome (26) 26
disease progression (25) 25
progression (24) 24
huntington's disease (22) 22
neurosciences (22) 22
risk (22) 22
abridged index medicus (21) 21
huntington disease (20) 20
adolescent (19) 19
huntington disease - diagnosis (17) 17
parkinsons disease (17) 17
research (17) 17
huntington disease - physiopathology (16) 16
diagnosis (15) 15
follow-up studies (15) 15
huntington disease - drug therapy (15) 15
longitudinal studies (15) 15
neurology (15) 15
risk factors (15) 15
severity of illness index (15) 15
clinical trials as topic (14) 14
genetics & heredity (14) 14
levodopa (14) 14
parkinson disease - physiopathology (14) 14
child (13) 13
clinical trials (13) 13
age of onset (12) 12
brain (12) 12
cohort studies (12) 12
disease (12) 12
huntington's chorea (12) 12
medical research (12) 12
aged, 80 and over (11) 11
animals (11) 11
antiparkinson agents - therapeutic use (11) 11
huntington disease - psychology (11) 11
levodopa - therapeutic use (11) 11
medicine, general & internal (11) 11
prospective studies (11) 11
retrospective studies (11) 11
therapy (11) 11
dose-response relationship, drug (10) 10
huntington disease - complications (10) 10
parkinson disease - genetics (10) 10
parkinsons-disease (10) 10
pharmacology & pharmacy (10) 10
studies (10) 10
age (9) 9
biomarkers (9) 9
canada (9) 9
depression (9) 9
genetic predisposition to disease (9) 9
genetic testing (9) 9
genotype (9) 9
huntingtons disease (9) 9
onset (9) 9
parkinson disease - diagnosis (9) 9
parkinson disease - metabolism (9) 9
parkinson disease - pathology (9) 9
time factors (9) 9
trinucleotide repeat (9) 9
disability (8) 8
dopamine transporter (8) 8
genome-wide association study (8) 8
levodopa - administration & dosage (8) 8
movement disorders (8) 8
neurodegenerative diseases (8) 8
parkinson disease (8) 8
prognosis (8) 8
selegiline - therapeutic use (8) 8
age-of-onset (7) 7
alleles (7) 7
biochemistry & molecular biology (7) 7
biomarker (7) 7
chi-square distribution (7) 7
child, preschool (7) 7
chorea (7) 7
dementia (7) 7
drug administration schedule (7) 7
drug therapy (7) 7
huntingtin protein (7) 7
mortality (7) 7
mutation (7) 7
neuroprotective agents - therapeutic use (7) 7
neuropsychological tests (7) 7
parkinson disease - diagnostic imaging (7) 7
predict-hd (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet Neurology, ISSN 1474-4422, 2017, Volume 16, Issue 8, pp. 620 - 629
Journal Article
Annals of Neurology, ISSN 0364-5134, 09/1998, Volume 44, Issue 3, pp. S160 - S166
In 1987, the DATATOP clinical trial was initiated to examine the benefits of deprenyl (selegiline) and a-tocopherol in slowing the progression of Parkinson's... 
TOCOPHEROL | SELEGILINE | DEPRENYL | NEUROSCIENCES | PROGRESSION | CLINICAL NEUROLOGY | PARKINSONS-DISEASE | LEVODOPA
Journal Article
The American Economic Review, ISSN 0002-8282, 4/2013, Volume 103, Issue 2, pp. 804 - 830
We use novel data to study genetic testing among individuals at risk for Huntington disease (HD), a hereditary disease with limited life expectancy. Although... 
Pregnancy | Utilities costs | Disease models | Huntington disease | Medical genetics | Genetic mutation | Human genetics | Symptoms | Retirement | Age | FAMILIES | BEHAVIOR | MUTATION | INSURANCE | RISK | COHORT | ECONOMICS | OVARIAN-CANCER | BRCA1 | Economic aspects | Research | Huntington's chorea | Genetic screening | Studies | Huntingtons disease | Economic models | Genetic disorders | Medical screening
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2004, Volume 351, Issue 24, pp. 2498 - 2508
Journal Article
Neurology, ISSN 0028-3878, 07/2018, Volume 91, Issue 1, pp. 19 - 20
Journal Article
Movement Disorders, ISSN 0885-3185, 2010, Volume 25, Issue S1, pp. S152 - S154
Journal Article
The American economic review, ISSN 0002-8282, 2013, Volume 103, Issue 5, pp. 1977 - 2002
Journal Article
Journal of Diabetes and Its Complications, ISSN 1056-8727, 12/2017, Volume 31, Issue 12, pp. 1719 - 1727
FDA-approved drug labels are an important source of information for clinicians who prescribe medications for treatment of diabetes. We reviewed drug labels to... 
Cardiovascular outcomes | Drug labels | Diabetes | ADD-ON | HEART-FAILURE | INSULIN | TREATMENT OPTIONS | HYPERGLYCEMIA | LIRAGLUTIDE | PATIENT-CENTERED APPROACH | ENDOCRINOLOGY & METABOLISM | YOUTH | OUTCOMES | TYPE-1 | United States - epidemiology | Diabetic Cardiomyopathies - mortality | Cardiovascular Diseases - prevention & control | Humans | Risk | Drug Approval | Diabetes Mellitus, Type 1 - complications | Hypoglycemic Agents - classification | Hypoglycemia - prevention & control | Cardiovascular Diseases - complications | Cardiovascular Diseases - epidemiology | Adult | Diabetic Cardiomyopathies - prevention & control | Diabetic Angiopathies - prevention & control | Hypoglycemia - chemically induced | Child | Diabetes Mellitus, Type 2 - complications | United States Food and Drug Administration | Hypoglycemic Agents - therapeutic use | Diabetic Angiopathies - chemically induced | Hyperglycemia - prevention & control | Diabetic Angiopathies - mortality | Drug Labeling - trends | Diabetes Mellitus, Type 1 - drug therapy | Diabetes Mellitus, Type 2 - blood | Animals | Diabetes Mellitus, Type 1 - blood | Diabetic Cardiomyopathies - epidemiology | Diabetic Angiopathies - epidemiology | Cardiovascular Diseases - chemically induced | Diabetes Mellitus, Type 2 - drug therapy | Diabetic Cardiomyopathies - chemically induced | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Safety and security measures | Type 1 diabetes | Hypoglycemic agents | Drug therapy | Labeling | Drug approval | Diabetes therapy | Prescription writing | Labels
Journal Article
JAMA, ISSN 0098-7484, 03/2014, Volume 311, Issue 12, pp. 1201 - 1202
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2/2014, Volume 111, Issue 7, pp. 2626 - 2631
Journal Article
Journal Article
Journal Article
Journal Article